Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments. However, about half of the patients who take these drugs stop within a year because of unwanted side effects. 1,2 For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback